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Chemokines play a fundamental role in lymphocyte development, mainly attributable to
the control of the correct localization in the proper microenvironments of cells undergoing
maturation. Natural killer (NK) cell development occurs in the bone marrow (BM) where
their localization is regulated by the balance of chemokine function in cell retention into
tissues and mobilization into circulation. In addition, NK cells from several extra-medullary
tissues are phenotypically and functionally different from their circulating counterpart sug-
gesting that maturation can be completed in organs other than BM. Indeed, a role of
chemokines in NK cell localization into tissues during homeostatic conditions is also docu-
mented. In this review, we summarize the current notion related to the relevance of several
chemokine/chemokine receptor axes in NK cell development with a focus on the regulation
of their expression and function.
Keywords: NK cell, chemokine receptor, transcription factors, microRNA, lymphocyte development and function,
bone marrow
GENERAL INTRODUCTION ON NATURAL KILLER CELL
DEVELOPMENT
Natural killer (NK) cells are innate lymphocytes that provide host
protection against infectious diseases and cancer. NK cells recog-
nize ligands expressed by infected and transformed cells through
germline encoded activating receptors resulting in the killing of
target cells and production of immunomodulatory cytokines (1).
Bone marrow (BM) represents the main site for NK cell devel-
opment, providing a full array of stimuli organized in complex
microenvironments and acting in concert to sustain NK cell dif-
ferentiation. Starting from the classical distinction of a committed
precursor (NKP: Lin−/CD122+/NK1.1−/CD49b−), an immature
(iNK: NK1.1+/CD49b−CD11blow/CD51low) and a mature NK
subpopulation (mNK: CD49b+/Ly49s+), the NK cell develop-
mental process has been progressively dissected through a more
detailed comprehension of the great cell diversity within each stage
(2–4). Recent findings better characterize the lineage commitment
process, with the identification of an earliest NK cell progeni-
tor in mouse BM that links the CLP and the NKP (5, 6), and is
characterized by the expression of the surface molecules CD127
(IL-7 receptor), CD244, CD27, and of the basic helix-loop-helix
transcription factor (TF) Id2.
A key marker of the NK cell lineage is CD27, a mem-
ber of the TNF receptor superfamily, whose expression, com-
bined with the integrin chain CD11b, defines four sequen-
tial developmental stages: CD11blowCD27low, CD11blowCD27high,
CD11bhighCD27high, and CD11bhighCD27low subsets (7). As a
final step, the most mature subset acquires the expression of
the inhibitory receptor KLRG1 that defines a cell subset with
reduced effector functions, decreased IL-15 responsiveness, and
proliferative capacity (8). However, our group demonstrated that
also this terminally differentiated subset is heterogeneous, since
the expression of the chemokine receptor CX3CR1 characterizes
an even later maturation stage with unique functional features and
localization within BM microenvironments (9).
TISSUE-SPECIFIC NK CELL MATURATION
It is important to note that, beside the BM-driven matura-
tion process, also extra-medullary sites contribute to guide NK
cell development, thus generating tissue-specific NK cell subsets
(Figure 1). NKPs have been found in murine thymus, spleen,
liver, and lymph nodes (LN), but it is still unknown whether
these cells are generated in situ or are recruited from BM.
Hepatic CD49b−NK cells uniquely express the integrin chain
CD49a and display the TNF-related apoptosis-inducing ligand
(TRAIL), through which they can trigger cell death in suscep-
tible targets (10–12). Although liver NK cell phenotype resem-
bles that of immature cells, accumulating evidence suggest that
CD49a+CD49b− hepatic NK cells represent a resident population,
able to mediate memory responses, and correspond to a different
subset compared to BM iNK, whereas CD49a−CD49b+ hepatic
NK cells are a migratory subset that mostly originate outside the
liver (12). More controversial is the stability of the CD49b− hepatic
subset, as adoptive transfer experiments allowed some groups to
demonstrate that this population can repopulate several organs
and give rise to CD49b+ cells (10, 13), while others evidenced that
CD49b− cells are a stable subset that can only repopulate liver
(12). An alternative pathway of NK cell development takes place
in the thymus (14), generating a phenotypically and function-
ally distinct subset characterized by the expression of the α-chain
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FIGURE 1 | Schematic model of chemoattractant receptor expression
during mouse NK cell development and of transcription factors involved
in NK cell commitment and maturation. Several stages of differentiation
have been defined during which NK cells progressively acquire maturation
markers (2–4). Three stages (I–III) corresponding to different levels of
functional competence were described in mature CD49b+ (DX5+) NK cells,
being CD27highCD11blow and CD11bhighCD27high fully competent and a later
stage of differentiation marked by the inhibitory receptor KLRG1 having
reduced functional capacity. Besides mNK, iNK are found in peripheral
tissues, such as liver and thymus, where they represent NK cells with
tissue-specific phenotype and functions possibly arising from a BM precursor.
Chemokine and S1P receptor expression is developmentally regulated and is
associated to selective functions in NK cell localization and maturation in BM.
For example, CX3CR1 and S1P5 play an important and non-redundant role in
mature NK cell egress from BM. Although, it is not known whether these two
receptors are co-expressed by the same cell or expressed by different cell
populations, prompting an investigation on how they co-operate to allow the
efficient export of NK cells into circulation. Chemokine receptor expression
overlaps that of several transcription factors active during NK cell
development. Indeed some of these transcription factors, including T-bet and
Myb were shown to directly affect chemokine and S1P receptor expression.
Shown are transcription factors at the stage where they play a role in
development. Asterisks identify chemoattractant receptors whose deficiency
affects NK cell development. Line width is proportional to expression levels.
of CD127 and high amounts of the TF GATA-3. The authors
reported that CD127+ NK cells also constitute a relevant frac-
tion of NK cells in LN that may arise from thymus due to their
CD11blowCD16−CD69highLy49low phenotype and to their selec-
tive reduction in athymic nude Foxn−/− mice. Nevertheless, other
authors found normal number of CD127+ NK cells in LN of
Foxn−/− mice (15).
REGULATION OF GENE EXPRESSION IN DEVELOPING NK
CELLS
Although the differential expression of maturation-related surface
markers can help to distinguish different stages of development,
the precise sequence and combination of stimuli controlling NK
cell acquisition of functional properties, organ-specific features,
inter-organ and intra-organ positioning, and chemokine receptor
expression require further investigation. One critical aspect
related to NK cell development is the transcriptional and post-
transcriptional regulation of mRNA expression of molecules asso-
ciated with developing NK cell phenotype and function. Several
TFs and, more recently, selected microRNA (miRNA) expression
were shown to be involved in the commitment to the NK cell
lineage and in NK cell maturation (16–18) (Figure 1).
E4-binding protein 4 (E4BP4), is a basic leucine zipper (bZIP)
TF required for NK cell development and maturation as its defi-
ciency leads to marked reduction of iNK and lack of mNK, without
affecting other hematopoietic cell lineages (19). E4BP4 promotes
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the expression of Id2 and GATA-3, and forced expression of Id2
in E4BP4-deficient mice partially rescued the NK cell deficiency.
Nevertheless, Id2 plays a critical role only for differentiation to
mNK (19, 20). Gordon et al. demonstrated that the shift from
immature TRAIL+CD11blow to CD49b+CD11bhi NK cells and
the parallel induction of Ly49 receptors in BM and liver require
the expression of Eomesodermin (Eomes), a member of the T-box
family of TFs (13). In this regard, a subset of less mature TRAIL+
NK cells that lacks CD49b and Eomes expression is expanded in
neonates, and preferentially resides in adult liver (10, 21). It has
been proposed that Eomes-dependent maturation is restricted by
the TF T-bet in Eomes−CD49b− iNK as NK cells with T-bet dele-
tion exhibit increased levels of Eomes expression and accelerated
maturation (13). Nevertheless, T-bet is still expressed in Eomes+
mature NK cells, suggesting that other factors expressed in mNK
cells circumvent T-bet to up-regulate Eomes expression (22).
Concerning miRNAs, conditional knockdown of the miRNA-
processing enzyme Dicer, which leads to a global impairment of
the miRNA biogenesis, results in decreased mature NK cell number
due to increased apoptosis of peripheral NK cells and accumula-
tion of immature NK cells (18). Accordingly, significant accumula-
tion of more immature CD27highCD11blow and a related decrease
of IFN-γ production have been observed also within miRNA-
150−/− NK cells (23). This was associated to higher stability of the
TF c-Myb, a direct target of miRNA-150 negatively regulated dur-
ing the transition from CD27highCD11blow to CD27lowCD11bhigh
NK cells (7). Similarly, miRNA-155 has been shown to enhance
IFN-γ production in human NK cells activated by IL-2/IL-18
(24). Differently from miRNA-150, in miRNA-155−/− mice, the
immature CD27highCD11blowLy49D−Ly49H− NK cell subset is
reduced, likely because miRNA-155 targets the pro-apoptotic fac-
tor Noxa, thus supporting survival and homeostasis of developing
NK cells (25). In human, miRNA-181 expression increases during
NK cell maturation and promotes NK cell differentiation by regu-
lating Notch signaling, essential for lymphocyte development (26).
CHEMOKINES AND LYMPHOCYTE DEVELOPMENT
Chemokines are small cytokines with pleiotropic functions, hav-
ing effect on a broad range of leukocytes and are thus critical
regulators of immune cell function (27). Based on the pres-
ence of conserved cysteine residues, there are two major (CXC
and CC) and two minor (C and CX3C) chemokine classes and
accordingly four classes of chemokine receptors (CXCR, CCR,
CX3CR, XCR). Another chemoattractant, the lipid sphingosine-
1-phosphate (S1P) and its receptors (S1P1–5) are required for
lymphocyte egress from lymphoid organs (28).
The chemokine system regulates the process of lymphocyte
generation, mainly by directing developing cell positioning in
successive compartmental niches, which provides exposure to spe-
cialized microenvironments in primary lymphoid organs. The
leading chemokine/chemokine receptor axis in hematopoiesis
is CXCL12/CXCR4, which regulates hematopoietic stem and
progenitor cell homing to BM, retention in specialized niches,
proliferation, and egress to the circulation (29, 30).
In regard to B cell lymphopoiesis, CXCL12/CXCR4 axis is
widely known to be crucial to maintain homeostatic levels of
B cell precursors in the proper BM anatomical sites (31–33).
More recently, a finely regulated post-receptor signaling was also
reported: in vitro long-term exposure of pro-B cells to CXCL12
induces their strong and sustained adhesion to VCAM-1, resulting
in prolonged CXCL12-induced focal adhesion kinase (FAK) phos-
phorylation in immature cells, and promotion of progenitor cell
growth, survival, and differentiation (34, 35). As long as cells dif-
ferentiate,CXCL12-induced FAK phosphorylation becomes short-
lived, decreasing adhesiveness of mature cells, and enhanced exit
in peripheral circulation. Besides this, changes in scaffold proteins
in cytosol or membrane and in the glycosylation pattern of CXCR4
occur during B cell maturation (36).
Concerning T cell maturation, it is well-established that CLPs
generated in BM reach the thymus through venules in the cortico-
medullary junctions, where their maturation process is regu-
lated by chemokine-driven migration from medulla toward outer
cortex and subcapsular zone, with a leading role for CCL19–
CCL21/CCR7, CCL25/CCR9, and CXCL12/CXCR4 axes (37). In
addition, CXCR4 acts on early thymocyte development as co-
stimulator of the pre-TCR, providing MAPK and PI3K-dependent
survival signals, and promoting the double negative (DN)3 to DN4
transition (38, 39). Recently, a crucial role in T cell selection and
development for the atypical receptor CCX-CKR has also been
documented, linked to its function as decoy/scavenger receptor
for CCR7 and CCR9 ligands (40).
In regard to NKT cells, development starts in thymus and is
completed in peripheral tissues, mainly in liver, where an impor-
tant role was recently attributed to CXCL16/CXCR6 axis. Absence
of CXCR6 leads to reduced number of mature NKT cells in liver
and accumulation of immature cells in BM and spleen, due to
altered trafficking and impaired maturation of thymus-derived
cells (41).
REGULATION OF CHEMOKINE RECEPTOR EXPRESSION IN NK
CELL DEVELOPMENT
Accumulating evidence indicates that the chemokine system can
influence NK cell development through the regulation of several
aspects of NK cell biology (42). NK cells change their chemokine
receptor expression profile during development in BM (Figure 1).
CXCR4 is highly expressed by NKP but its expression progres-
sively decreases on iNK and mNK. On the other hand, CXCR3 and
CCR1 are up-regulated on CD49b+KLRG1−mNK. CX3CR1 and
the chemoattractant receptor S1P5 are prevalently present on more
differentiated NK cells, being the expression of CX3CR1 mainly
confined to the KLRG1+ subset that poorly expresses CXCR4 and
CXCR3 (9, 43, 44). CXCR6 is expressed only by immature cells, a
phenotype that is maintained also by liver resident CD49b−Ly49−
NK cells.
NK cell development is severely impaired in CXCR4 condition-
ally deficient adult mice where NK cells are markedly reduced in
number and display reduced cytotoxic function and IFN-γ pro-
duction capacity (45). The defect was associated with reduced
number of NK cell precursors and decreased proliferation rate
of CXCR4 deficient iNK. Of note, this effect could be related to
regulation of developing NK cell maintenance into maturation
niches, as we previously demonstrated that CXCR4 differentially
affects NK cell retention into BM according to their matura-
tion stage (9, 44). Accordingly, transient CXCR4 desensitization
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within BM promotes NK cell exit, likely facilitating the mobilizing
effect of other chemoattractant receptors (46). In this regard, it
was demonstrated that a fraction of CXCL12 abundant reticular
(CAR) cells that express high levels of CXCL12, co-express IL-15
and IL-15Ralpha and can be found in close proximity with NK
cells in vivo, thus suggesting that CAR cells trans-present IL-15
and provide CXCL12 to NK cells during development (45). The
same authors also evidenced that CXCL12 enhances the effect of
IL-15 on mNK cell generation from lymphoid precursors and iNK
cells in vitro, suggesting that CXCR4 acts as a co-stimulus during
NK cell differentiation.
Reduced NK cell number in several tissue compartments and
impaired killing capacity of NK cells were also evidenced in CCR5
but not in CCR1 deficient mice under normal conditions. The
defect was attributed to a slight reduction of NK cell precursor
number and to a lower in vivo proliferation capacity of CCR5
deficient NK cells. The authors suggested that reduced number
of proliferating NK cells may result either from incorrect local-
ization of these cells in their specific niche or from deficiency in
co-stimulatory signals provided by CCR5 (47).
Because CX3CR1 is expressed by a small fraction of mouse
NK cells, to evaluate its role under physiological conditions we
recently made use of a CX3CR1–GFP reporter mouse, where GFP
is expressed under the control of CX3CR1 promoter. The subset
identified by means of GFP expression, was expanded in all ana-
lyzed tissues of CX3CR1-deficient mice indicating that CX3CR1
regulates the homeostatic number of NK cells (48). A role of
the CX3CR1 in NK cell maturation was also suggested, as NK
cells from CX3CR1-deficient mice displayed a more pronounced
degranulation capacity and mobilization from BM into blood,
respectively after in vitro and in vivo activation. The increased
number of CX3CR1-deficient NK cells in BM could be associated
to their reduced exit in circulation by competitive adoptive trans-
fer experiments. Similarly, S1P5 provides an egress signal to NK
cells, allowing their export from the BM and the LNs (43).
Using CXCR6–GFP reporter mice, Paust et al. demonstrated
that CXCR6 is important for the development and/or survival
of CXCR6+ NK cells exclusively in the liver. CXCR6−/−mice
have significantly reduced GFP+ cells in liver, compared to
CXCR6+/−mice, but normal number of GFP− cells. The authors
were able to show that the phenotype observed is not due to
altered trafficking, but is likely due to the absence of CXCR6-
mediated NK cell localization/survival in sinusoidal endothelium,
which constitutively presents CXCL16 (49).
How are the effects of multiple chemokine receptors regu-
lated, to finely tune the different steps of NK cell maturation?
One level of control is the differential expression of chemotac-
tic ligands by BM cellular niches. Of note, beside CXCL12, other
chemokines are expressed in BM, although their cellular sources
are less clear. Human BM stromal cells express CCL2, CX3CL1, and
CXCL8, and, more specifically, osteoclasts can produce CCL5 and
CCL9 during steady state (50, 51). A similar pattern of chemokine
expression can be detected in mouse BM (48, 52). However,
responsiveness to the chemokine environment requires an efficient
control of chemotactic receptor gene expression, which represents
a second mechanism of regulation. Interestingly, miR-150 knock-
down significantly increased CXCR4 expression in mononuclear
hematopoietic cells and affected their BM localization (53). It is
likely that the effect of miR-150 on CXCR4 mRNA expression is
Myb-dependent as this TF can associate the CXCR4 gene pro-
moter and activate a CXCR4 reporter gene in transfection assays.
Similarly to CXCR4, Myb expression decreases during NK cell
maturation paralleling the increased expression of miR-150, thus
suggesting that reciprocal regulation of these three factors plays a
critical role in NK development during homeostasis. Regulation of
CXCR4 function by miRNAs may also occur at the signaling level
as another regulator of NK cell development, miR-181, was shown
to repress PTEN expression in NKT cells thus allowing proper
CXCL12-stimulation of Akt without affecting CXCR4 expression
during thymic development (54).
Regulation of chemoattractant receptor expression by TFs in
developing NK cells was also documented. T-bet promotes expres-
sion of S1P5 but not S1P1 by mNK, and its deficiency leads
to impaired CXCR3 expression (55). Interestingly, Eomes− and
Eomes+ NK cells express different repertoires of homing receptors
consistent with their preferential anatomic localization (liver ver-
sus BM respectively) thus allowing the correct maturation of liver
versus BM NK cell populations (13). Indeed, CD49b−Eomes− NK
cells expressed the integrin chain αv and the chemokine receptors
CXCR3 and CXCR6 at greater levels relative to Eomes+ NK cells
and expressed substantially lower levels of the S1P receptors S1P1
and S1P5 than Eomes+ NK cells. As we could not detect CXCR3
on CD49b− (DX5−) NK cells in BM and spleen, expression of
CXCR3 by this subset may be a unique property of hepatic NK
cells (44). CXCR3 and CXCR6 expression in liver was linked to
Eomes expression as repression of this TF caused re-expression
of these chemokine receptors. Thus, Eomes and T-bet may regu-
late the differential expression of chemokine receptors at different
stages of NK cell development.
ID proteins are essential for NK cell development and matura-
tion, thanks to their ability to inhibit E-protein and in particular
E2A, a family of TFs that act as transcription activators or repres-
sors (20, 56). Id2 and E2A have been suggested to regulate emigra-
tion of NK cells from the BM as Id2−/−E2A−/−mNK number was
reduced in peripheral blood but was normal in BM. Although in
Id2−/−E2A−/−mice, mNK fail to express the adhesion molecule
CD11b, no defect in chemokine receptor expression, i.e., CCR1,
CCR5, or CX3CR1 could be observed. Nevertheless, a regulation
of chemokine receptor expression by E2A is possible as CCR7
expression may depend on ID protein-mediated E-protein down-
regulation in thymocytes (57). Although mouse NK cells do not
express CCR7, this mechanism of transcription may be relevant
in humans where CCR7 plays a role in the localization of the NK
cells in LN.
All together the studies presented herein evidence an emerging
role of chemoattractant receptors in NK cell development. Thus,
the identification of the molecular factors that regulate expres-
sion and function of these receptors and of BM niches where they
can find and respond to their respective ligands will undoubtedly
expand our comprehension of NK cell biology in the future.
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